DCT

3:16-cv-02356

Boehringer Ingelheim Pharma GmbH & Co KG v. Hetero USA Inc

General
Filed
04/26/16
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (06/21/16)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
64%
Defendant
Party
Name
Ratings
L2E
Attorney